nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case of spontaneous systemic immunity to melanoma associated with cure after amputation for extensive regional recurrence
|
Judge, Joshua M. |
|
2013 |
62 |
8 |
p. 1327-1334 |
artikel |
2 |
A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cells
|
Sarhan, Dhifaf |
|
2013 |
62 |
8 |
p. 1359-1368 |
artikel |
3 |
Avidity of onconeural antibodies is of clinical relevance
|
Totland, Cecilie |
|
2013 |
62 |
8 |
p. 1393-1396 |
artikel |
4 |
Evaluating combinations of costimulatory antibody–ligand fusion proteins for targeted cancer immunotherapy
|
Hornig, Nora |
|
2013 |
62 |
8 |
p. 1369-1380 |
artikel |
5 |
Ficolin-2 and ficolin-3 in women with malignant and benign ovarian tumours
|
Szala, Agnieszka |
|
2013 |
62 |
8 |
p. 1411-1419 |
artikel |
6 |
Gamma delta T cells are activated by polysaccharide K (PSK) and contribute to the anti-tumor effect of PSK
|
Inatsuka, Carol |
|
2013 |
62 |
8 |
p. 1335-1345 |
artikel |
7 |
Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patients
|
Hobo, Willemijn |
|
2013 |
62 |
8 |
p. 1381-1392 |
artikel |
8 |
Increase in CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis
|
Arihara, Fumitaka |
|
2013 |
62 |
8 |
p. 1421-1430 |
artikel |
9 |
Intratumoral treatment of smaller mouse neuroblastoma tumors with a recombinant protein consisting of IL-2 linked to the Hu14.18 antibody increases intratumoral CD8+ T and NK cells and improves survival
|
Yang, Richard K. |
|
2013 |
62 |
8 |
p. 1303-1313 |
artikel |
10 |
Intravenous infusion of phage-displayed antibody library in human cancer patients: enrichment and cancer-specificity of tumor-homing phage-antibodies
|
Shukla, Girja S. |
|
2013 |
62 |
8 |
p. 1397-1410 |
artikel |
11 |
Mistletoe lectin has a shiga toxin-like structure and should be combined with other Toll-like receptor ligands in cancer therapy
|
Maletzki, Claudia |
|
2013 |
62 |
8 |
p. 1283-1292 |
artikel |
12 |
Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients
|
Morse, Michael A. |
|
2013 |
62 |
8 |
p. 1293-1301 |
artikel |
13 |
The chemotherapeutic agent topotecan differentially modulates the phenotype and function of dendritic cells
|
Trojandt, Stefanie |
|
2013 |
62 |
8 |
p. 1315-1326 |
artikel |
14 |
The Twelfth International Conference on Progress in Vaccination Against Cancer (PIVAC 12), Nottingham, UK, 11–13 September 2012: insights into the dynamics of anti-tumour immunity and the development of cancer vaccines
|
Malhi, Sumanjeet Kaur |
|
2013 |
62 |
8 |
p. 1431-1437 |
artikel |
15 |
TLR8 stimulation enhances cetuximab-mediated natural killer cell lysis of head and neck cancer cells and dendritic cell cross-priming of EGFR-specific CD8+ T cells
|
Stephenson, Ryan M. |
|
2013 |
62 |
8 |
p. 1347-1357 |
artikel |